The disrupted patient & physician journey: What pharma needs to know
The patient and physician journey has been disrupted. What will treatment pathways look like in the new normal? Read how pharma marketers can adapt to emerging needs.
Senior Manager
Daisy is a Senior Research Manager based in Rotterdam. With an expertise in coordinating large multi-country projects in the healthcare arena, Daisy is a Research Manager based in SKIM's Rotterdam Office. She joined SKIM in 2006 as part of SKIM’s Healthcare team and has conducted both quantitative and qualitative research for pharmaceutical companies, device manufacturers, and other B2B enterprises.
Her knowledge of the analytical techniques and software required for methodology design, execution, and interpretation make her a strong addition to SKIM. Over the past 5 years, she has focused on designing and executing qualitative research studies in various industries. Daisy graduated with a degree in Biology from Simon Fraser University, B.C., Canada.
The patient and physician journey has been disrupted. What will treatment pathways look like in the new normal? Read how pharma marketers can adapt to emerging needs.
Learn how MCDA can help pharma & healthcare marketers obtain robust data for decision-making when the target population or treating physicians are limited
How pharmaceutical brands Analyze patient needs to maximize your impact on treatment success Emotions affect…
Conventional research approaches to understanding prescribing behavior lack the insights required today A physician’s decision…